These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 849019)

  • 21. Epidemiology of mixed Schistosoma mansoni and Schistosoma haematobium infections in northern Senegal.
    Meurs L; Mbow M; Vereecken K; Menten J; Mboup S; Polman K
    Int J Parasitol; 2012; 42(3):305-11. PubMed ID: 22366733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement components and immunoglobulins in patients with schistosomiasis.
    Madwar MA; O'Shea JM; Skelton JA; Soothill JF
    Clin Exp Immunol; 1978 Dec; 34(3):354-8. PubMed ID: 743807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity.
    Chisango TJ; Ndlovu B; Vengesai A; Nhidza AF; Sibanda EP; Zhou D; Mutapi F; Mduluza T
    BMC Infect Dis; 2019 Mar; 19(1):219. PubMed ID: 30832614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-Schistosoma IgG responses in Schistosoma haematobium single and concomitant infection with malaria parasites.
    Morenikeji OA; Adeleye O; Omoruyi EC; Oyeyemi OT
    Pathog Glob Health; 2016 Mar; 110(2):74-8. PubMed ID: 27092873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypersensitivity to parasite proteolytic enzyme in schistosomiasis.
    Senft AW; Maddison SE
    Am J Trop Med Hyg; 1975 Jan; 24(1):83-9. PubMed ID: 1111360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune responses and immunoregulation in relation to human schistosomiasis in Egypt. I. Effect of treatment on in vitro cellular responsiveness.
    Barsoum IS; Gamil FM; Al-Khafif MA; Ramzy RM; El Alamy MA; Colley DG
    Am J Trop Med Hyg; 1982 Nov; 31(6):1181-7. PubMed ID: 6890774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in the humoral immune responses after chemotherapy in single and co-infected individuals with Schisosoma haematobium and Plasmodium falciparum.
    Zinyowera S; Muchaneta-Kubara CE; Mutapi F; Midzi N; Ndlovu PD; Mduluza T
    Cent Afr J Med; 2006; 52(9-12):104-11. PubMed ID: 20353134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PREVALENCE AND INTENSITY OF SINGLE AND MIXED SCHISTOSOMA MANSONI AND SCHISTOSOMA HAEMATOBIUM INFECTIONS IN PRIMARY SCHOOL CHILDREN IN RACHUONYO NORTH DISTRICT, HOMABAY COUNTY, WESTERN KENYA.
    Amollo DA; Kihara JH; Kombe Y; Karanja SM
    East Afr Med J; 2013 Feb; 90(2):36-44. PubMed ID: 26866100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Delayed hypersensitivity during experimental helminthiasis: in vitro and in vivo study of the phenomenon in the guinea-pig. Preliminary results in man].
    Vernes A; Biguet J; Floc'h F; Lefebvre MN
    Pathol Biol (Paris); 1972 Jan; 20(1):23-9. PubMed ID: 4552027
    [No Abstract]   [Full Text] [Related]  

  • 30. Stimulation of hamster and human lymphocyte cultures by soluble egg antigens (SEA) of Schistosoma haematobium and S. mansoni.
    Weiss N; Oberlin UP; Degrémont A
    Trans R Soc Trop Med Hyg; 1976; 70(4):317-21. PubMed ID: 1034358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency of haematuria and proteinuria among Schistosoma haematobium infected children of two communities from Liberia and Tanzania.
    Tanner M; Holzer B; Marti HP; Saladin B; Degrémont AA
    Acta Trop; 1983 Sep; 40(3):231-7. PubMed ID: 6138974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokine and chemokine profile of the innate and adaptive immune response of Schistosoma haematobium and Plasmodium falciparum single and co-infected school-aged children from an endemic area of Lambaréné, Gabon.
    Ateba-Ngoa U; Adegnika AA; Zinsou JF; Kassa Kassa RF; Smits H; Massinga-Loembe M; Mordmüller B; Kremsner PG; Yazdanbakhsh M
    Malar J; 2015 Feb; 14():94. PubMed ID: 25890010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specificity of antibody and cellular immune responses in human schistosomiasis.
    Barral-Netto M; Hofstetter M; Cheever AW; Ottesen EA
    Am J Trop Med Hyg; 1983 Jan; 32(1):106-13. PubMed ID: 6186153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on heterologous immunity in schistosomiasis. 6. Observations on cross-immunity to Ornithobilharzia turkestanicum, Schistosoma bovis, S. mansoni, and S. haematobium in mice, sheep, and cattle in Iran.
    Massound J; Nelson GS
    Bull World Health Organ; 1972; 47(5):591-600. PubMed ID: 4540679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The significance of proteinuria and haematuria in Schistosoma haematobium infection.
    Wilkins HA; Goll P; Marshall TF; Moore P
    Trans R Soc Trop Med Hyg; 1979; 73(1):74-80. PubMed ID: 442186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schistosomiasis in infants and preschool-aged children: Infection in a single Schistosoma haematobium and a mixed S. haematobium-S. mansoni foci of Niger.
    Garba A; Barkiré N; Djibo A; Lamine MS; Sofo B; Gouvras AN; Bosqué-Oliva E; Webster JP; Stothard JR; Utzinger J; Fenwick A
    Acta Trop; 2010 Sep; 115(3):212-9. PubMed ID: 20303925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Schistosoma mekongi infection in man: cellular immune responses and modulating mechanisms.
    Barral-Netto M; Hofstetter M; Gustavo dos Santos J; Cheever AW; Ottesen EA
    Clin Exp Immunol; 1982 Jan; 47(1):65-73. PubMed ID: 6212174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T and B cell reactivity to a 42-kDa protein is associated with human resistance to both schistosomiasis mansoni and haematobium.
    El Ridi R; Farouk F; Sherif M; Al-Sherbiny M; Osman A; El Gengehi N; Shoemaker CB
    J Infect Dis; 1998 May; 177(5):1364-72. PubMed ID: 9593026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Historical aspects of the risk factors of Schistosoma intercalatum schistosomiasis].
    Jusot JF; Simarro P; De Muynck A
    Sante; 1996; 6(3):165-72. PubMed ID: 8764451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing the benefits of five years of different approaches to treatment of urogenital schistosomiasis: A SCORE project in Northern Mozambique.
    Phillips AE; Gazzinelli-Guimaraes PH; Aurelio HO; Ferro J; Nala R; Clements M; King CH; Fenwick A; Fleming FM; Dhanani N
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006061. PubMed ID: 29220347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.